|
IDUA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.160400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.381800E-02 |
| Normal-vs-Stage2 |
1.600820E-01 |
| Normal-vs-Stage3 |
8.084400E-01 |
| Normal-vs-Stage4 |
1.396200E-01 |
| Stage1-vs-Stage2 |
8.302400E-01 |
| Stage1-vs-Stage3 |
1.270770E-01 |
| Stage1-vs-Stage4 |
5.487600E-01 |
| Stage2-vs-Stage3 |
2.042000E-01 |
| Stage2-vs-Stage4 |
7.037600E-01 |
| Stage3-vs-Stage4 |
1.827040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.151900E-02 |
| Normal-vs-AfricanAmerican |
4.091600E-01 |
| Normal-vs-Asian |
7.421900E-02 |
| Caucasian-vs-AfricanAmerican |
9.909400E-01 |
| Caucasian-vs-Asian |
3.299400E-01 |
| AfricanAmerican-vs-Asian |
5.209800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.459900E-02 |
| Normal-vs-Female |
9.163700E-02 |
| Male-vs-Female |
5.839000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.290370E-01 |
| Normal-vs-Age(41-60Yrs) |
5.634200E-02 |
| Normal-vs-Age(61-80Yrs) |
4.930800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.495000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.902200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.220800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.603200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.875600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.959600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.846200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.41079999483563E-08 |
| Classical-VS-Follicular |
4.140800E-01 |
| Classical-VS-Other |
5.672800E-01 |
| Classical-VS-Normal |
3.049600E-02 |
| Tall-VS-Follicular |
3.46919999949513E-07 |
| Tall-VS-Other |
1.170420E-01 |
| Tall-VS-Normal |
2.827100E-04 |
| Follicular-VS-Other |
7.757600E-01 |
| Follicular-VS-Normal |
2.139700E-02 |
| Other-VS-Normal |
4.263000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.235850E-02 |
| Normal-vs-N1 |
1.466030E-02 |
| N0-vs-N1 |
1.719810E-01 |
|
|
